CYP2C8 and lung adenocarcinoma: A sensitive qPCR-based method with an optimal normalization procedure was presented here for the assessment of the copy numbers of paclitaxel-metabolizing CYP2C8 and CYP3A4 in lung adenocarcinoma samples.